Women’s health

Histology slides
#Endometriosis #Women's health

Oriva appoints Arbat as CEO, advances endometriosis asset 

Women’s health company Oriva Therapeutics has appointed Dr Agnès Arbat as Chief Executive Officer.  Arbat joins with more than 25 years of experience in the pharmaceutical industry, which Oriva says demonstrate a strong track record across clinical development, medical affairs and commercial strategy in women’s health.  Arbat… Read More

#News

#Clinical trial #Freya Biosciences #Women's health

Freya Biosciences reports positive data on IVF therapeutic 

Immunology company Freya Biosciences has reported positive Phase I results for its treatment for IVF-related embryo implantation failure.  FB301, a defined multi-strain Lactobacillus consortium developed using Freya’s Dyscover platform, was safe and well tolerated in healthy female subjects, with all primary and secondary endpoints met.  The trial was a… Read More

#News

Endometriosis
#Artificial intelligence (AI) #Automation / robotics #Endometriosis #Women's health

Can AI shrink the drug development timelines for endometriosis?

DDW Deputy Editor Diana Turner speaks to the team behind an ambitious project to identify a novel drug target for endometriosis by the end of the year. The Advanced Research & Invention Agency (ARIA), through its AI Scientist programme, has awarded a £500,000 grant to fund a collaboration… Read More

#Exclusive Content

#Alzheimer's #Brain #Breast cancer #Dementia #Genetics #Immunology #Institute of Cancer Research #King's College London #Neuroscience #Parkinson's #Respiratory syncytial virus #Women's health

DDW Highlights: 17 March 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, research on the brain proved a popular theme, unlocking insights into Alzheimer’s, dementia… Read More

#Podcasts

#Alzheimer's #Brain #Breast cancer #Dementia #Genetics #Immunology #Institute of Cancer Research #King's College London #Neuroscience #Parkinson's #Respiratory syncytial virus #Women's health

This week in Drug Discovery (9 – 13 March) 

News round-up for 9 – 13 March February by Bruno Quinney, Content Team at DDW.  This week, research on the brain has proved a popular theme, unlocking insights into Alzheimer’s, dementia and cancer. Elsewhere, a genetic target could provide new routes to breast cancer treatment.  The top stories: … Read More

#News

Neurons with Lewy bodies
#Alzheimer's #Mayo Clinic #Neuroscience #Women's health

Parkinson’s protein linked to faster Alzheimer’s progression in women

Alzheimer’s-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a Parkinson’s-related protein, according to a Mayo Clinic study.  The findings suggest that when alpha-synuclein — a protein linked to Parkinson’s disease — accumulates alongside Alzheimer’s pathology, it may drive… Read More

#Editor's Choice #News

Ovarian cancer cells
#Cancer research #European Innovation Council #Ovarian cancer #Women's health

EIC awards €2.5m grant for gynaecological cancer drug 

The European Innovation Council (EIC) has awarded €2.5 million to biotechnology company Step Pharma to accelerate the development of dencatistat for CTPS2 null gynaecological tumours.  The funding, which consists of a €2.5 million grant and potentially up to €10 million in equity investment, is part of the EIC’s Accelerator Award,… Read More

#Cancer Research #News #Regulatory

#AI #Drug discovery #Women's health

Partnership to develop treatments for gynaecological diseases 

Tejin Pharma has partnered with pharmaceutical company Aska Pharmaceutical to develop treatments for gynaecological diseases.  As per the agreement, the companies will collaborate to accelerate the early-stage drug discovery process aimed at identifying innovative therapeutic candidates.   The companies intend to develop novel small-molecule drug candidates, a process which… Read More

#News

#CureLab Oncology #DNA #endogene.bio #Endometriosis #Genetics #Junevity #MHRA #Ocular diseases #Oncology #Regulatory #UK government #University of California San Francisco #Women's health

DDW Highlights: 20 January 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, new research in women’s health uncovered significant findings related to endometriosis and… Read More

#Podcasts

#CureLab Oncology #DNA #endogene.bio #Endometriosis #Genetics #Junevity #MHRA #Ocular diseases #Oncology #Ovarian cancer #Regulatory #UK government #University of California San Francisco #Women's health

This week in Drug Discovery (12 – 16 January) 

News round-up for 12 – 16 January by Bruno Quinney, Content Team at DDW.  This week in DDW, new research in women’s health has uncovered significant findings related to endometriosis and ovarian cancer. Elsewhere, can ageing be reversed?  The top stories:    Discovery reveals endometriosis is not… Read More

#News

Endometrial biopsy
#endogene.bio #Endometriosis #Women's health

Discovery reveals endometriosis is not one disorder but many

New research from Paris-based biotech endogene.bio suggests endometriosis is molecularly heterogeneous across patients, lesion sites, and cell types.  This molecular heterogeneity has important implications for how endometriosis treatments are studied and developed.   Treating the disease as a single entity may help explain why many clinical… Read More

#Editor's Choice #Editor's Pick #News

Woman suffering from hot flushes
#Bayer #FDA #Menopause #Women's health

Bayer’s new approach to hot flashes receives FDA approval

The US Food and Drug Administration (FDA) has approved Lynkuet (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,1 neurokinin 1 (NK1) and neurokinin 3 (NK3) receptor antagonist, for the treatment of moderate to severe hot flashes due to menopause.  Inhibition of Substance P… Read More

#News #Regulatory

Biomarkers concept
#Biomarkers #Drug discovery #Endometriosis #Genetics / genomics #Neurodegenerative disorders #Neuroscience #Women's health

New podcast: Innovative uses for biomarkers in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative uses for biomarkers in drug discovery”, which covers two articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “How biomarkers can help discover new treatments for women’s health” and… Read More

#News

Gold compound
#Alzheimer's #BioInnovation Institute #Biotech hubs #Cognition Therapeutics #India #Interview #Market reporting #Neurodegenerative disorders #Neuroscience #Pregnancy #Start-ups #Women's health

Podcast: Where are scientists making waves in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled “Where are scientists making waves in drug discovery?”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “How pharma is targeting advances in Alzheimer’s treatments”, “The start-up disrupting… Read More

#News

#Endometriosis #Interview #Women's health

The drug discovery challenges facing endometriosis

DDW Editor Reece Armstrong speaks to Dr Piraye Yurttas Beim about the unmet need for patients with endometriosis and how research could lead to new treatments for ovarian health. RA: What are the current unmet needs for women with endometriosis? PB: Endometriosis is an inflammatory pain condition estimated to impact more… Read More

#Exclusive Content

#GLP-1 #Weight loss #Women's health

New DDW Highlights podcast: 31 March 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Weight loss drugs have been… Read More

#News